Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Ghiani

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Comparative Effectiveness Research|November 28, 2025
Patient characteristics, burden of disease, healthcare resource utilization and costs in acute myeloid leukemia - a retrospective observational study with German claims dataKatja Greth, Moritz Lehne, Marco Ghiani, et al.
Frontiers in Neurology|December 22, 2023
Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical recordsErwan Muros-Le Rouzic, Marco Ghiani, Evi Zhuleku, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 18, 2021
Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related eventsFränce Hardtstock, Zeki Kocaata, Thomas Wilke, et al.
European Journal of Haematology|December 26, 2023
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and SpainMoritz Lehne, K Martin Kortüm, Karthik Ramasamy, et al.
International Journal of Colorectal Disease|March 20, 2023
Burden of disease among patients with prevalent Crohn's disease: results from a large German sickness fundEvi Zhuleku, Beatriz Antolin-Fontes, Andras Borsi, et al.
Therapeutic Advances in Gastroenterology|November 10, 2022
Real-world outcomes associated with switching to anti-TNFs <i>versus</i> other biologics in Crohn's Disease patients: A retrospective analysis using German claims dataEvi Zhuleku, Beatriz Antolin-Fontes, Andras Borsi, et al.
Journal of Comparative Effectiveness Research|May 1, 2026
Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in EuropeEllen Brodin, Annie Young, Florian Langer, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Comparative Effectiveness Research|November 28, 2025
Patient characteristics, burden of disease, healthcare resource utilization and costs in acute myeloid leukemia - a retrospective observational study with German claims dataKatja Greth, Moritz Lehne, Marco Ghiani, et al.
Frontiers in Neurology|December 22, 2023
Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical recordsErwan Muros-Le Rouzic, Marco Ghiani, Evi Zhuleku, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 18, 2021
Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related eventsFränce Hardtstock, Zeki Kocaata, Thomas Wilke, et al.
European Journal of Haematology|December 26, 2023
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and SpainMoritz Lehne, K Martin Kortüm, Karthik Ramasamy, et al.
International Journal of Colorectal Disease|March 20, 2023
Burden of disease among patients with prevalent Crohn's disease: results from a large German sickness fundEvi Zhuleku, Beatriz Antolin-Fontes, Andras Borsi, et al.
Therapeutic Advances in Gastroenterology|November 10, 2022
Real-world outcomes associated with switching to anti-TNFs <i>versus</i> other biologics in Crohn's Disease patients: A retrospective analysis using German claims dataEvi Zhuleku, Beatriz Antolin-Fontes, Andras Borsi, et al.
Journal of Comparative Effectiveness Research|May 1, 2026
Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in EuropeEllen Brodin, Annie Young, Florian Langer, et al.
Pageof 2